SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Logerfo Michael (Last) (First) (Middle) C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 (Street) SCHAUMBURG IL 60195 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 04/19/2011	3. Issuer Name and Ticker or Trading Symbol Sagent Holding Co. [ SGNT ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Legal Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock(1)	13,395	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option to Buy	(2)	12/11/2019	Common Stock	12,758	$4.31	D
Stock Option to Buy	(3)	07/23/2020	Common Stock	12,758	$4.31	D
Stock Option to Buy	(4)	08/15/2018	Common Stock	19,138	$4.23	D
Stock Option to Buy	(5)	08/15/2018	Common Stock	24,242	$4.23	D
Stock Option to Buy	(6)	12/02/2020	Common Stock	25,517	$11.6	D

Explanation of Responses:

1. Represents shares of Common Stock deemed beneficially owned by the undersigned on account of the automatic conversion of its 105,000 ordinary shares of Sagent Holding Co., a Cayman Islands company, in connection with its reincorporation as a Delaware corporation pursuant to a Certificate of Conversion filed with the Secretary of State of the State of Delaware (the "Reincorporation"), and the related one-for-7.8378 reverse stock split to be implemented in connection therewith. The Reincorporation will become effective prior to the closing of the initial public offering.

2. Stock option granted on December 11, 2009 and vests 25% per year over four years.

3. Stock option granted on July 23, 2010 and vests 25% per year over four years.

4. Stock option granted on August 15, 2008 and vests upon the achievement of certain milestones.

5. Stock option granted on August 15, 2008 and vests 25% per year over four years.

6. Stock option granted on December 2, 2010 and vests 25% per year over four years.

	/s/ Michael Logerfo	04/19/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.